CD96 and lung adenocarcinoma: The distribution of T‐cell immunoglobulin and immunoreceptor tyrosine‐based inhibitory motif domain, CD96 and CD226 on CD8+ tumour‐infiltrating lymphocytes is imbalanced in patients with lung adenocarcinoma